European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b and canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated) - immunologicals for canidae, live viral vaccines - dogs - active immunisation of dogs from six weeks of age.to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leukopenia and viral excretion caused by canine parvovirus,to prevent clinical signs and reduce viral excretion caused by canine parainfluenza virus.

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine parainfluenza virus (cpiv) , canine adenovirus (cav) , canine parvovirus (cpv) , inactivated leptospira interrogans icterohaemorrhagiae , leptospira interrogans canicola , leptospira vaccine (vet.) - solution for injection (im) - each ml (1 dose) contains: lyophilisate (live attenuated): canine distemper virus, strain cdv bio 11/a 103.1-5. tcid50 canine adenovirus type 2, strain cav-2 bio 13 103.6-5.3. tcid50 canine parvovirus type 2b, strain cpv-2b bio 12/b 104.3-6.6 tcid50 canine parainfluenza type 2 virus, strain cpiv-2 bio 15- 103.1:5.1 tcid50 tcid – tissue culture infectious dose suspension (inactivated): leptospira interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089 gmt 1:51 alr leptospira interrogans serogroup canicola, serovar canicola, strain mslb 1090 gmt 1:51 alr leptospira kirschneri serogroup grippotyphosa, serovar grippotyphosa, strain mslb 1091 21:40 alr leptospira interrogans serogroup australis, serovar bratislava, strain mslb 1088 gmt 1:51 alr alr - antibody micro agglutination-lytic reaction gmt-geometric mean titre

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - canine adenovirus, canine distemper virus, canine parvovirus - lyophilisate and solvent for suspension for injection - live viral vaccine - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - canine adenovirus, canine distemper virus, canine parainfluenza virus, canine parvovirus, leptospira interrogans serogroup australis, leptospira interrogans serogroup canicola, leptospira interrogans serogroup icterohaemorrhagiae, leptospira kirschneri serogroup grippotyphosa, rabies virus - lyophilisate and suspension for suspension for injection - live viral and inactivated viral and bacterial vaccine - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - canine adenovirus, canine distemper virus, canine parainfluenza virus, canine parvovirus - lyophilisate for suspension for injection - live viral vaccine - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - canine adenovirus, canine distemper virus, canine parvovirus - lyophilisate and solvent for suspension for injection - live viral vaccine - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - canine adenovirus, canine distemper virus, canine parvovirus - lyophilisate and solvent for suspension for injection - live viral vaccine - dogs

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - canine distemper virus, strain n-cdv; canine adenovirus type 2, strain manhattan; canine parvovirus, strain nl-35-d; gentamicin - misc. vaccines or anti sera - canine distemper virus, strain n-cdv vaccine-viral active 0.0 p; canine adenovirus type 2, strain manhattan vaccine-viral active 0.0 p; canine parvovirus, strain nl-35-d vaccine-viral active 0.0 p; gentamicin antibiotic other 30.0 ug/ml - immunotherapy